Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment

被引:82
作者
Carrio, R
Bathe, OF
Malek, TR
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Calgary, Dept Surg, Calgary, AB, Canada
[3] Univ Calgary, Dept Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
关键词
D O I
10.4049/jimmunol.172.12.7315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although much is known concerning the immunobiology of CD8(+) T memory cells, the initial events favoring the generation of CD8(+) T memory cells remain poorly defined. Using a culture system that yields memory-like CD8(+) T cells, we show that 1 day after Ag encounter, Ag-activated T cells developed into memory-like T cells, but this optimally occurred 3 days after Ag encounter. Key phenotypic, functional, and molecular properties that typify central memory T cells were expressed within 48 h when the activated CD8(+) T cells were cultured with IL-7 or IL-15 in the absence of Ag or following transfer into normal mice. These data support a model whereby Ag activation of naive CD8(+) T cells not only programs effector cell expansion and contraction but the potential to develop into a memory cell which ensues in an Ag-free environment containing IL-7 or IL-15.
引用
收藏
页码:7315 / 7323
页数:9
相关论文
共 52 条
  • [1] Immunological memory and protective immunity: Understanding their relation
    Ahmed, R
    Gray, D
    [J]. SCIENCE, 1996, 272 (5258) : 54 - 60
  • [2] Programmed contraction of CD8+ T cells after infection
    Badovinac, VP
    Porter, BB
    Harty, JT
    [J]. NATURE IMMUNOLOGY, 2002, 3 (07) : 619 - 626
  • [3] IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8+ T cells
    Bathe, OF
    Dalyot-Herman, N
    Malek, TR
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (08) : 4511 - 4517
  • [4] Beckett S, 2002, CALL CENT MAG, V15, P8
  • [5] TNF-Mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide
    Bilsborough, J
    Uyttenhove, C
    Colau, D
    Bousso, P
    Libert, C
    Weynand, B
    Boon, T
    Van den Eynde, BJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (06) : 3053 - 3060
  • [6] 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
    Cannons, JL
    Lau, P
    Ghumman, B
    DeBenedette, MA
    Yagita, H
    Okumura, K
    Watts, TH
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1313 - 1324
  • [7] Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection
    Clarke, SRM
    Barnden, M
    Kurts, C
    Carbone, FR
    Miller, JF
    Heath, WR
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (02) : 110 - 117
  • [8] Quantitation of phosphotyrosine signals in human prostate cell adhesion sites
    Cress, AE
    [J]. BIOTECHNIQUES, 2000, 29 (04) : 776 - +
  • [9] Curtsinger JM, 1998, J IMMUNOL, V160, P3236
  • [10] Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC
    Dalyot-Herman, N
    Bathe, OF
    Malek, TR
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (12) : 6731 - 6737